We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Procalcitonin in Pleural Pleuritis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01011881
First Posted: November 11, 2009
Last Update Posted: June 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens
  Purpose
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.

Condition Intervention
Pleuritis Pleural Empyema Other: pleural level of procalcitonin

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux

Further study details as provided by Centre Hospitalier Universitaire, Amiens:

Enrollment: 34
Study Start Date: October 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients with pleuritis Other: pleural level of procalcitonin
no intervention

Detailed Description:

Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.

Second periods : Patient with pleuritis . Empyema or not

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with pleuritis
Criteria

Inclusion Criteria:

  • Pleuritis
  • Hospitalisation

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01011881


Locations
France
CHU Amiens
Amiens, France, 80000
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens
  More Information

Responsible Party: Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier: NCT01011881     History of Changes
Other Study ID Numbers: PI09-DR-DOUADI
First Submitted: November 10, 2009
First Posted: November 11, 2009
Last Update Posted: June 9, 2016
Last Verified: June 2016

Keywords provided by Centre Hospitalier Universitaire, Amiens:
pleuritis
empyema
procalcitonin

Additional relevant MeSH terms:
Empyema
Pleurisy
Empyema, Pleural
Suppuration
Infection
Inflammation
Pathologic Processes
Pleural Diseases
Respiratory Tract Diseases
Respiratory Tract Infections


To Top